• Post-Doctoral Research Fellow - Computational Immunology

    Job ID
    Regular Full-Time
    Fred Hutchinson Cancer Research Center
    Biostatistics, Bioinformatics and Computational Biology
  • Overview

    Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.



    The laboratory of Dr. Harlan Robins, Head of Computational Biology, is recruiting a postdoctoral research scholar to study the interaction between the adaptive immune system and cancer.

    This position will come with a competitive postdoc-level salary with great benefits for a two-year position with some possibility of extension.

    Dr. Robins focuses on the quantitative analysis of the adaptive immune system. His approach takes advantage of new high-throughput sequencing technology developed by Dr. Robins and his collaborators. His group is isolating and sequencing millions of adaptive immune receptor rearrangements to profile the adaptive immune system. With this new technology, he is working toward a comprehensive description of the T cell repertoire and studying the dynamics of immune response. He is applying this technology in multiple clinical settings including HSC transplant and cancer immunotherapy.

    The position will involve technology development, algorithm creation, and applications.  Primary research goals will be to develop high-throughput technologies to assess the specific immune response to cancer and to learn how the tumor evades this response and how the response can be resuscitated to effectively fight tumors.


    Applicants must have a:

    • PhD in biological science, math, physics, or another computation-heavy discipline
    • Either computer programming proficiency or some programming and molecular biology laboratory experience
    • Clear ability for independent research

    Applicants should have some of the following skills and experience:

    • Work well in team environments; strong communication/organization skills; detail-oriented
    • Experience with high performance computing environments and cloud computing environments is a plus
    • Experience with analyzing sequencing data is considered a strong asset
    • Applicants must have a demonstrated publication track record

    To apply, please submit your application with the following:

    • Statement of research interests
    • CV
    • Names and email addresses of three references
    • Two representative publications or preprints (if available)

    Our Commitment to Diversity

    We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at escmail@fredhutch.org or by calling 206-667-4700.


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed